ACCP 2016 Annual Meeting

Save the date for the 2016 Annual Meeting of the American College of Clinical Pharmacology, "Clinical Pharmacology: Discovery and Application in the Era of Precision Medicine" September 25th - 27th in Bethesda, MD.

As you plan your meeting schedule for 2016, make sure the 2016 ACCP Annual Meeting is on your calendar! Stay on the cutting edge of clinical pharmacology developments with an exciting mix of current topics guided by globally-recognized experts in the field. Registration fees for the 3-Day meeting start as low as $800 for ACCP Members, $315 for ACCP Student Members and $960 for government colleagues and members of specific sister organizations.

Registration opens in early April and includes:

  • Symposia that balance laboratory and clinical pharmacologic science
  • A broad spectrum of speakers representing academia, industry, regulatory and clinical entities
  • Numerous sessions with interactive, dynamic audience participation
  • Opportunities to network and build important relationships during evening catered receptions, Lunch & Awards events and session breaks
  • Lunch & Awards events and session breaks
  • Student & Trainee events: Student Abstract Awards, career-focused tutorials and Poster Tours
  • Exhibits providing the latest tools and technology

2016 Preliminary Schedule
Those with asterisks are scheduled to offer CE credit.

Saturday, September 24th - Pre-meeting Workshops

8:00 am – noon
WORKSHOP 1: Translational Pharmacokinetics/Pharmacodynamics in Biotherapeutic Minimum Anticipated Biological Effect Level Dose Selection and Novel Protein Scaffold - Co-chairs: Honghui Zhou, PhD, US Head, Pharmacological Modeling, Janssen Research & Development, LLC and Rong Shi, PhD, Senior Research Investigator, Bristol-Myers Squibb

**WORKSHOP 2: Combating HIV/AIDS: Tx, PGx and PrEP - Co-chairs: Sam Harirforoosh, PharmD, PhD, Associate Professor, East Tennessee State Univ and Ganesh Cherala, PhD, Senior Scientist, CONRAD

1:30 pm – 5:30 pm
WORKSHOP 3: Improving Therapeutics to Better Care for the Senior and the Young - Co-chairs: SW Johnny Lau, PhD, Senior Clinical Pharmacologist, US Food & Drug Administration and Thomas Eissing, PhD, Head of Systems Pharmacology CV, Bayer Technology Services GmbH

**WORKSHOP 4: The Other Bound of the Therapeutic Window: Exposure-Safety Analysis to Inform Dosing Decisions in Oncology - Co-chairs: Justin C. Earp, US Food & Drug Administration and Anshu Marathe, PhD, Scientific Lead for Biosimilars and Senior Reviewer, Div of Pharmacometrics, US Food & Drug Administration

Sunday, September 25th - Symposia

8:00 am – noon
**SYMPOSIUM 1: Clinical Pharmacology as Cornerstone for Development of Products Under the Animal Rule: Determining an Effective Dose in Humans - Co-chairs: Nitin Mehrotra, PhD, Team Leader, Div of Pharmacometrics, US Food & Drug Administration and Kimberly Bergman, PharmD, Team Leader, Div of Clinical Pharmacology 4, US Food & Drug Administration

8:00 am – 9:30 am
SYMPOSIUM 2: A 360? View of Immunogenicity: Qualitative and Quantitative Assessments to Understand its Implications on Pharmacokinetics, Safety and Efficacy - Co-chairs: Chaitali Passey, PhD, Senior Research Investigator, Bristol-Myers Squibb and Sumit Rawal, Regeneron Pharmaceuticals Inc

8:00 am – 9:30 am
Understand its Implications on Pharmacokinetics, Safety and Efficacy - Co-chairs: Chaitali Passey, PhD, Senior Research Investigator, Bristol-Myers Squibb and Sumit Rawal, Regeneron Pharmaceuticals Inc

10:00 am – noon
SYMPOSIUM 3: Helping Advance the Immuno-Oncology Revolution: Trends in Translational Immuno-Oncology - Co-chairs: Sree Kasichayanula, BPharm, PhD, Principal Scientist, Amgen Inc and Yu-Nien (Tom) Sun, PhD, Senior Director, Janssen BioPharmaceutics

1:30 pm – 5:30 pm
SYMPOSIUM 4: Clinical Development of Biologics: Current Strategy, Challenges and Future Considerations - Co-chairs: Gaurav Bajaj, PhD, Senior Research Investigator, Bristol-Myers Squibb and Ping Zhao, PhD, Lead, Program of Physiologically-based Pharmacokinetic and Pharmacodynamic Modeling, US Food & Drug Administration

1:30 pm – 3:00 pm
SYMPOSIUM 5: Addressing Opioid Dependence: Now is the Time - Co-chairs: Lorraine M. Rusch, MSc, PhD, Vice President Scientific Affairs, Vince and Associates and Michael J. Fossler, PharmD, PhD, Vice President Qualitative Sciences, Trevena Inc

3:30 pm – 5:30 pm
**SYMPOSIUM 6: Treatment of Hepatitis C with Direct Acting Antiviral Drugs: Opportunities and Challenges - Co-chairs: Vikram Arya, PhD, Senior Staff Fellow, Office of Clinical Pharmacology, US Food & Drug Administration and Shirley Seo, PhD, Team Leader, Office of Clinical Pharmacology, US Food & Drug Administration

Monday, September 26th - Symposia 

8:00 am – noon
**SYMPOSIUM 7: Establishing Biosimilarity: The European Perception, Experience and Future Trends - Co-chairs: Hildegard Sourgens, MD, PhD, President Elect, European Federation for Exploratory Medicines Development, and Hartmut Derendorf, PhD, Chairman, Distinguished Professor of Pharmaceutics, V. Ravi Chandran Professor in Pharmaceutical Sciences, Univ of Florida

8:00 am – 9:30 am
SYMPOSIUM 8: Informing Pediatric Development Programs: Leveraging Big Data - Co-chairs: Jeffrey Barrett, PhD, Vice President, Interdisciplinary Pharmacometrics Program, Sanofi and Lily (Yeruk) Mulugeta, PharmD, Pediatric Clinical Pharmacologist, US Food & Drug Administration

10:00 pm – 12:00 pm
**SYMPOSIUM 9: 
Little Children, Big Challenges: The Problems for Neonatal Drug Trials & the Way Forward - Co-chairs: Jian Wang, PhD, Senior Clinical Pharmacologist, US Food & Drug Administration and John van den Anker, MD, PhD, Chief, Div of Clinical Pharmacology, Children's National Health System

Noon – 1:30 Awards Session

1:30 pm – 5:30 pm
SYMPOSIUM 10: Clinical Pharmacology Strategies to Assess Drug Safety at an Early Stage of Clinical Development - Co-chairs: Suraj Bhansali, PhD, Manager, Clinical Pharmacology, Novartis Pharmaceutical Corp, Xiao Hu, PhD, Senior Pharmacometrician, Biogen

1:30 pm – 3:00 pm
SYMPOSIUM 11: Cutting Edge/Abstract Presentations - Co-chairs: Lawrence J. Cohen, PharmD, Professor of Pharmacotherapy, Univ of North Texas System Coll of Pharmacy and Walter K. Kraft, MD, Associate Professor, Clinical Pharmacology, Thomas Jefferson Univ

3:30 pm – 5:30 pm
**SYMPOSIUM 12: Rethinking Labeling for Improved Utility and Comprehension - Co-chairs: Joseph Grillo, PharmD, Associate Director for Labeling and Health Communications, US Food & Drug Administration and Julie Bullock, PharmD, Director, d3 Medicine

Tuesday, September 27th - Symposia 

8:00 am – noon
**SYMPOSIUM 13: Orphan Drug Development in Adults and Pediatrics: Industry, Academia and Regulatory Perspectives - Co-chairs: Vijay Ivaturi, PhD, Research Assistant Professor, Univ of Maryland and TBD

8:00 am – 9:30 am
SYMPOSIUM 14: Clinical Applications of Physiologically-based Pharmacokinetics/Pharmacodynamics for Pediatrics: Academic, Industry and Regulatory Perspectives - Co-chairs: Jennifer Sheng, PhD, PharmD, Associate Director, Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb and Diansong Zhou, PhD, Director Quantitative Clinical Pharmacology, AstraZeneca

10:00 am - noon
SYMPOSIUM 15: Combination Therapy in Oncology: Challenges and Strategies in Clinical Pharmacology - Co-chairs: Yilong Zhang, PhD, Principal Scientist, Clinical Pharmacology, Modeling and Simulation, Amgen Inc and Satyendra Suryawanshi, PhD, Associate Director, Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb

Noon – 1:30 Awards Session

1:30 pm – 5:30 pm
SYMPOSIUM 16: Clinical Pharmacology Strategies in Precision Medicine-based Drug Development and Preventive Medicine - Co-chairs: Gangadhar Sunkara, PhD, Executive Director, Novartis Inst of Biomedical Research, Manoj Jadhav, PhD, Research Scholar, Univ of Florida and Jinshan Shen, PhD, Director, Clinical Pharmacology, Vertex Pharmaceuticals

**SYMPOSIUM 17: TBD

The Bethesda North Marriott Hotel & Conference Ctr is accessible from all three major airports in the Washington /Baltimore area. Travel by train is easy with the White Flint Metro Stop on Metro's Red Line located directly across from the hotel. We are confident you will enjoy this facility uniquely designed with meetings in mind.

ACCP remains committed to offering Continuing Medical Education (CME) and Continuing Pharmacy Education (CPE) credits for our educational events, provided to meeting attendees at no additional cost.

We look forward to welcoming you to an outstanding 2016 ACCP Annual Meeting. Come to learn, network and be part of a progressive ACCP!